Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history adds a new revision label v3.4.3 and removes the previous label v3.4.2. This reflects an internal update to the page’s version history.
    Difference
    0.1%
    Check dated 2026-03-11T17:47:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 was added to the history. The old notice about government funding lapse was removed.
    Difference
    0.7%
    Check dated 2026-02-11T09:23:14.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding/status notice was added and the page version updated to v3.4.1, while the previous version v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T05:47:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI enhancements include a Show glossary option and color-coded highlights for added/deleted items. The revision label updates from v3.3.4 to v3.4.0, and the No FEAR Act Data capitalization is adjusted.
    Difference
    0.9%
    Check dated 2026-01-28T04:16:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new record history entry, Revision: v3.3.4, was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:41:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The new screenshot shows an added 'Revision: v3.3.3' line and removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer, reflecting a minor site revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:07:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.